www.techsolutions.bio.br minas gerais’ overview: biotechnology

[email protected] Tel.: 31-3555-3479 / Cel.: 31-9967-5998

Dr. Roberto Machado Silva

www.techsolutions.bio.br

MINAS GERAIS’ OVERVIEW: BIOTECHNOLOGY




Belo Horizonte

Brasília

Rio de JaneiroSão Paulo




Minas Gerais - Main figures

TERRITORY. 587,000 Km2 . Larger than countries such as France, Sweden, and Spain

ECONOMY. In 2009, increase was 7.5% (FJP). GDP: US$ 143 billion. Exports: 2011 – US$ 41,3 bi. Second largest industrial park of the country. A leader in Brazil for mining, metallurgy, coffee, dairy, biotechnology, engineering, management,consultancy,etc.

SOCIAL. Population: around 20.0 million inhabitants . Children at school: 2,6 million. 18 thousand elementary schools

INFRA-STRUCTURE. 265.000 km of roads (23.000km paved). 5,329 km of railways. 66 airports – 1 international and industrial. 18,5% of total energy generation in Brazil. Broad telecom network: 4,15M fixed lines and 8,8M mobile lines




Knowledge is responsible for 55% of the world capital.

Organization for Economic Cooperation and Development (OECD)




• Minas Gerais is the 2nd state in Brazil harboring biotechnologic based companies which comprises 30% of the national enterprises.

• Minas Gerais has important universities such as UFMG and various research institutes with tradition in Human and Animal Medicine, Biochemistry, Pharmacy and Agronomy.

• UFMG has more than 160 researchers with a Ph.D. in biological sciences and more than 60% of its patents are related to biotechnology.

• Biotechnology is very promising in terms of technological development of Minas Gerais.

The Potential of Biotechnology inMinas Gerais




Structutring Project: Biotechnology Cluster

Source: State Secretariat of Science, Technology and Higher Education - SECTESSlides and information extracted from "SECTES Presentation". Autororized use




• Innovation: provide environment for innovation.

• Innovation in Business: actions and support cooperation between enterprises and institutions of science and technology.

• Regional and Sectorial Development: increase the competitiveness of economic sectors with high technological content.

Key Points




Promote and coordinate research activities, development and innovation in biotechnology applied to human and animal health, agribusiness and environment, creating partnerships between academy and industry.

Promote and manage training programs to achieve competitive advantage focusing on market trends for the next 5 years:

• Market reposition companies of biotechnology.

• Merging different technologies: biotech, IT, electronics and engineering for development of new biotechnology products.

Targets




COMPETITIVENESS

TRAINING

MANAGEMENT

BUREAU

MARKETING

MINAS

BIOPOLE

CENTER OF

EXCELLENCE IN

BIOINFORMATICS

CERTIFICATION

MINAS

BIOTECH

CLUSTER

Developed Products

IEL/FIEMGSEBRAE - MG

Sindusfarq

FunedCPqRR – Fiocruz Mnas

Sindusfarq




Start: 2007 Deliver: 2010

3 Clusters working separately Unique Identity: Minas BiotechBrand Adoption

53 Companies: 15 Viçosa, 20 RMBH e 18 TMAP 82 Companies: 19 Viçosa, 30 RMBH, 33 TMAP

Nonexistance of internal supply chainCompanies providing services and selling products within and between Clusters

National and International missions with limited visibility.

Minas Biotech missions with representativeness and generating business and partnershipsEUA - Inovatec 2010Flandres – Consolidating partnershipUruguai – Internacional Office for ClustersFrança - Nord-Pas-de-Callais

Starting Point versus Current Situation



www.techsolutions.bio.brStart: 2007 Deliver: 2010

Actions without a focus on Competitiveness and interaction between university/company

2 studies focused on competitiveness and introducting to modern biotechnology;Action planning along with the companies;

Few interaction between companies within and between poles, and with incubated companies and researchers

Consolidation of Inovatec as a Business, interaction and Technology Transfer environment:Minas Biotec Space: researchers, cluster companies, incubated and Anchors (Hertape-Calier, 2009 e DCN - EUA, 2010)Innovation meetings along with partner SIMI: 2009 - 85 participants and 21 meetings in Technological Showcase2010 - 6 Anchor Companies in Tecnological demands

Nonexistance of specialized services and impeller Anchors of research and services

Minas Biopole FormatationImplantation and strengthening of CEBio and of the State’s Bioinformatics Network

Starting Point versus Current Situation




32 Companies 30 Companies

19 Companies

81 Companies




17%

29%

16%

38%

Graphic 1 - Distribution of Minas Biotech Companies by Business Segment

Animal: health, reprodution, foods

Agribusiness: plants, clones, GMO

Environment.

Human health

Business Segment

• Distribution of Companies by size:• RMBH : 70% are micro and small • TMAP: 58% are micro and small • Viçosa: 85% are micro and small




Revenue




Biotech Expertises

HUMAN DIAGNOSTICS

MICROELETRONICS& TELECOMS

CATTLE GENETICS

AGRIBUSINESS




OTHERS TECNOLOGYCAL AND POLITICS INFRASTRUTURES




Year: 2008

• UFMG – 101 patents, of which 10 were licensed

• UFV – 34 patents, of which 5 were licensed

• UFU – 16 patents, of which 3 are in the process of licensing

• UFOP - 7 patents

• EMBRAPA CORN AND SORGHUM – 2 patents

Patents in Biotechnology Area




Technological Parks

Implementation




Empresas

Attraction of R&D CentersPolitic of Attraction of R&D Centers

Attraction of Enterprises: articulation of the key players involved in the attraction of R & D centers for the state of Minas Gerais

http://www.ieprox.com/files/Beeldmateriaal/Siemens_petrol1.bmp




19 Incubators Supported

Incubators




Publics Universities

UNIMONTES

UFVJM

UFTMUFMG

UFVUFLA

UFJF

UFOP

UNIFEI

UFU

UNIFENAS

UEMG

FHA

FJP

FEDERAL UNIVERSITIES

STATE UNIVERSITIES

UFSJ




THINKING GLOBAL, ACTING LOCAL

Proactive action in fund raising and establishment of international

partnerships in order to support the development of Science, Technology,

Innovation and Higher Education in Minas Gerais.




High level of integrity, quality and honesty;

Customized projects development;

Expertise in several areas: Biotechnology, Energy, Environment, Information Technology,Development and Project Management;

Consolidated network in the market and scientific enviroment;

TS conducts its operations from Belo Horizonte-MG.

Who is Tech Solutions?




Thank You

Dr. Roberto Machado SilvaMobile: 31 9967-5998

www.techsolutions.bio.br minas gerais’ overview: biotechnology

Documents